Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03318939 |
|---|---|
| Brief Title: | Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation |
| First Submitted : | October 10, 2017 |
| First Submitted that Met QC Criteria : | October 20, 2017 |
| First Posted : | October 24, 2017 |
| Certification/Extension First Submitted : | April 1, 2024 |
| Certification/Extension First Posted : | January 26, 2024 |
| Last Update Submitted that Met QC Criteria : | April 1, 2024 |
| Last Update Posted : | April 3, 2024 |